Spectral TMS (s-TMS)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of California, Los Angeles
- Study ID
- NCT04040062
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial Magnetic Stimulation — DEVICETranscranial magnetic stimulation (TMS) is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression. Using pulsed magnetic fields, transcranial magnetic stimulation therapy stimulates the part of the brain thought to be involved with mood regulation. These magnetic fields do not directly affect the whole brain; they only reach about 2-3 centimeters into the brain directly beneath the treatment coil.As these magnetic fields move into the brain, they produce very small electrical currents. These electrical currents activate cells within the brain, causing them to rewire, a process called neuroplasticity.
Study Details
This study will analyze the feasibility, safety, and tolerability of administering repetitive Transcranial magnetic stimulation(TMS) at frequencies other than standard 10 Hz. This study will enroll 50 subjects who will undergo one quantitative electroencephalograph, one TMS procedure to determine the appropriate frequency and intensity for treatment, weekly mood/symptom assessments, and up to 30 TMS treatments. Subjects will be asked to participate for up to 6 weeks.
Key Dates
- Start date
- Jun 25, 2019
- Status verified
- Mar 2026
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: SCCSubjects will be treated according to their frequency response pattern which may show one or more distinct frequencies of stimulation that generated increased SCC
Primary Outcome Measure
Inventory of Depressive Symptoms- Self report [ Time Frame: Weekly ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California | Los Angeles | California | 90024 | - |
Find similar trials in Los Angeles, CA
By condition
By specialty
By research site
Related Studies
- A Phase I/II Study of PDC-1421 for Treating Depression in Cancer PatientsPHASE1/PHASE2 · Not Yet Recruiting · BioLite, Inc. · Los Angeles, California
- Closed-Loop Deep Brain Stimulation for Major DepressionRecruiting · Andrew Krystal · San Francisco, California
- Biomarker-guided rTMS for Treatment Resistant DepressionPHASE3 · Recruiting · Weill Medical College of Cornell University · Stanford, California
- Near Infrared Spectroscopy (NIRS) for Assessment of DepressionRecruiting · University of California, San Francisco · San Francisco, California